Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
about
The experience of physicians in pharmacogenomic clinical decision support within eight German university hospitals.The challenges of implementing pharmacogenomic testing in the clinic.Care and cost consequences of pediatric whole genome sequencing compared to chromosome microarray.Toward health technology assessment of whole-genome sequencing diagnostic tests: challenges and solutions
P2860
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@en
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@nl
type
label
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@en
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@nl
prefLabel
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@en
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@nl
P2093
P2860
P50
P356
P1476
Test Pricing and Reimbursement in Genomic Medicine: Towards a General Strategy.
@en
P2093
Angela Brand
Athanassios Vozikis
Christina Mitropoulou
Federico Innocenti
George P Patrinos
Lada Leyens
Manousos E Kambouris
Marc S Williams
Milan Macek
Ming Ta Michael Lee
P2860
P304
P356
10.1159/000449152
P577
2016-09-28T00:00:00Z